Skip to main content
. Author manuscript; available in PMC: 2021 Mar 24.
Published in final edited form as: Cancer Prev Res (Phila). 2019 May 28;12(8):557–566. doi: 10.1158/1940-6207.CAPR-19-0053

Fig. 1.

Fig. 1.

Consort flow diagram of subject accrual into the trial. * The patient withdrew prior to starting on study medication due to relocation to another state. ** withdrew by MD due to adverse event deemed not related to study medication.